| Descriptor English: | Ephrin-A1 | ||||||
| Descriptor Spanish: |
Efrina-A1
| ||||||
| Descriptor Portuguese: | Efrina-A1 | ||||||
| Descriptor French: | Éphrine A1 | ||||||
| Entry term(s): |
B61 Secreted Protein, Endothelium EFNA1 EPLG1 Eck Ligand Eck RPTK Ligand Endothelium Secreted Protein B61 Ephrin A1 Epl1 Protein LERK 1 Protein LERK-1 Protein Ligand, Eck RPTK Ligand, Eck |
||||||
| Tree number(s): |
D12.644.276.500.100 D12.776.395.550.448.300 D12.776.467.500.100 D12.776.543.287.100 D12.776.543.484.500.300 D12.776.543.550.418.300 D23.529.500.100 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D036382 | ||||||
| Scope note: | An ephrin that was originally identified as the product of an early response gene induced by TUMOR NECROSIS FACTORS. It is linked to the CELL MEMBRANE via a GLYCOINOSITOL PHOSPHOLIPID MEMBRANE ANCHOR and binds EPHA2 RECEPTOR with high affinity. During embryogenesis high levels of ephrin-A1 are expressed in LUNG; KIDNEY; SALIVARY GLANDS; and INTESTINE. |
||||||
| Allowable Qualifiers: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
| Previous Indexing: |
Proteins (1990-2002) |
||||||
| Public MeSH Note: | 2003; ENDOTHELIUM SECRETED PROTEIN B61 (now Ephrin-A1) was indexed under PROTEINS 1990-2002, |
||||||
| History Note: | 2003; use EPHRIN-A1 (NM) 1990-2002 |
||||||
| DeCS ID: | 37366 | ||||||
| Unique ID: | D036382 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 2003/01/01 | ||||||
| Date of Entry: | 2002/07/02 | ||||||
| Revision Date: | 2010/06/25 |
-
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors
|
|
Ephrin-A1
- Preferred
| Concept UI |
M0181712 |
| Scope note | An ephrin that was originally identified as the product of an early response gene induced by TUMOR NECROSIS FACTORS. It is linked to the CELL MEMBRANE via a GLYCOINOSITOL PHOSPHOLIPID MEMBRANE ANCHOR and binds EPHA2 RECEPTOR with high affinity. During embryogenesis high levels of ephrin-A1 are expressed in LUNG; KIDNEY; SALIVARY GLANDS; and INTESTINE. |
| Preferred term | Ephrin-A1 |
| Entry term(s) |
B61 Secreted Protein, Endothelium EFNA1 EPLG1 Eck Ligand Eck RPTK Ligand Endothelium Secreted Protein B61 Ephrin A1 Epl1 Protein LERK 1 Protein LERK-1 Protein Ligand, Eck RPTK Ligand, Eck |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
